Hypodermic Needles Market size was valued at USD 4.39 billion in 2024 and is expected to cross USD 7.75 billion by the end of 2037, registering more than 4.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of hypodermic needles is estimated at USD 4.55 billion. The growth of the market can be attributed to the rising prevalence of chronic and infectious diseases such as Hepatitis B and Hepatitis C, along with the increasing number of diagnostic tests to treat such diseases. The Centers for Disease Control and Prevention estimates that 296 million people worldwide are infected with hepatitis B, while 58 million are infected with hepatitis C. According to the World Health Organization, global hepatitis C infections affect about 58 million people, and 1.5 million new infections occur each year. In addition, 1.5 million new cases of chronic hepatitis B are reported each year, with 296 million chronic hepatitis B infections in 2019. The increasing number of patients with chronic and infectious diseases has led to a surge in demand for hypodermic needles, as they are used to administer medications and vaccines to these patients. These needles are designed to deliver medication directly into the bloodstream, allowing for more efficient delivery of the medication and reducing the risk of infection.
In addition to these, factors that are believed to fuel the growth of hypodermic needles market include an increasing prevalence of chronic and Noncommunicable diseases (NCDs), a growing geriatric population, rising demand for injectable drugs, and increasing investments in healthcare infrastructure. The CDC reports that 6 out of 10 adults in the United States have at least one chronic disease. WHO estimates that NCDs account for 41 million deaths each year, representing 74% of all global deaths. With the rise in chronic NCDs, the need for medical treatments and procedures has also increased significantly. This has given rise to a higher demand for hypodermic needles market, as they are needed to administer medications and fluids to the patient.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.6% |
|
Base Year Market Size (2024) |
USD 4.39 billion |
|
Forecast Year Market Size (2037) |
USD 7.75 billion |
|
Regional Scope |
|
Product Type (Safety, Non-safety)
The global hypodermic needles market is segmented and analyzed for demand and supply by product type into safety hypodermic needles, and non-safety hypodermic needles. Out of these, the safety hypodermic needles segment is estimated to gain the largest market share of about 56% in the year 2037. The growth of the segment can be attributed to the increasing demand for safety needles in hospitals and clinics, as well as the growing awareness among healthcare professionals about the need for safe and hygienic practices, which is driving the growth of this segment. Additionally, the rising incidence of needle-stick injuries has resulted in the adoption of safety needles to reduce the risk and ensure patient safety. In Accordance with the CDC, the number of injuries caused by contaminated needles and other sharp devices among hospital-based healthcare personnel exceeds 385,000 injured every year. This equates to over 1,000 injuries a day.
Application (Drug Delivery, Vaccination, Blood Specimen Collection)
The global hypodermic needles market is segmented and analyzed for demand and supply by application into drug delivery, vaccination, blood specimen collection. Out of these, the drug delivery segment is estimated to gain a significant market share of about 46% in the year 2037. The growth of the segment can be attributed to the rising prevalence of chronic diseases, increasing adoption of injectable drugs, and growing demand for self-administration of drugs by patients, which is encouraging the manufacturers to focus on product innovation and development. Additionally, technological advancements in injection devices are also expected to drive the drug delivery segment growth. Furthermore, the presence of a wide range of advanced injection devices such as auto-injectors, pen injectors, and jet injectors is expected to contribute to segment growth.
Our in-depth analysis of the global market includes the following segments:
|
By Product Type |
|
|
By Application |
|
|
By End User |
|
North American Market Forecast
The share of hypodermic needles market in North America, amongst the market in all the other regions, is projected to be the largest with a share of about 37% by the end of 2037. The growth of the market can be attributed majorly to the increasing prevalence of chronic diseases such as diabetes and cardiovascular diseases, along with the rising geriatric population in the region. According to the Centers for Disease Control and Prevention's latest findings, approximately 37.3 million people in the US have diabetes, which represents 11.3% of the total population of the country. There are 28.7 million people diagnosed with diabetes, including 28.5 million adults and a total of 96 million people have prediabetes who are 18 years old or older. Hypodermic needles are effective tools for treating diabetes as they allow precise delivery of insulin directly into the bloodstream. This helps to regulate blood sugar levels safely and efficiently. In addition, technological advancements in the production of hypodermic needles, as well as increasing awareness among healthcare personnel, are also expected to contribute to market growth.
APAC Market Statistics
The Asia Pacific hypodermic needles market is estimated to be the second largest, registering a share of about 27% by the end of 2037. The growth of the market can be attributed majorly to the increasing demand for safety needles and the increasing number of hospitals in the region. Rising awareness about the risks of infections and the need for sterility in medical procedures has driven the demand for hypodermic needles as they are designed to reduce the risk of infection. Additionally, the increasing number of healthcare facilities and the presence of major pharmaceutical companies in the region are expected to drive market growth. With the growing population in the region, there is an increased need for healthcare facilities such as hospitals, clinics, and medical practices to serve the growing demand for medical services. Healthcare facilities need hypodermic needles for a variety of medical procedures, from administering vaccines to drawing blood.
Europe Market Forecast
Further, the hypodermic needles market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2037. The growth of the market can be attributed majorly to the increasing number of surgeries and the rising use of disposable needles in healthcare settings to minimize the risk of infection among patients. Additionally, the growing demand for minimally invasive surgeries, the rising popularity of self-administered drug delivery systems, and the increasing number of biopharmaceutical companies are expected to boost the demand for hypodermic needles in Europe. Self-administration of drugs provides people with a more convenient and cost-effective way to administer medication and perform medical procedures. Additionally, they reduce the risk of errors and reduce the amount of time it takes to administer medications and treatments. Furthermore, favorable government policies such as reimbursement for medical devices and increasing healthcare expenditure are expected to drive market growth in the region.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?